Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-12-16
2008-12-02
Robinson, Hope A (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S012200, C435S007100
Reexamination Certificate
active
07459429
ABSTRACT:
The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5324650 (1994-06-01), Obzansky et al.
patent: 5359030 (1994-10-01), Ekwuribe
patent: 5641670 (1997-06-01), Treco et al.
patent: 5672662 (1997-09-01), Harris et al.
patent: 5681811 (1997-10-01), Ekwuribe
patent: 5733761 (1998-03-01), Treco et al.
patent: 5981214 (1999-11-01), Skoultchi
patent: 5994127 (1999-11-01), Selden et al.
patent: 6340742 (2002-01-01), Burg et al.
patent: 6528313 (2003-03-01), LeMouellic et al.
patent: 6583272 (2003-06-01), Bailon
patent: 6710028 (2004-03-01), Lehmann
patent: 3924705 (1991-01-01), None
patent: 539167 (1993-04-01), None
patent: 584876 (1994-03-01), None
patent: 605963 (1994-07-01), None
patent: 1064951 (2001-01-01), None
patent: WO 92/16555 (1992-10-01), None
patent: WO 93/25212 (1993-12-01), None
patent: WO 94/20069 (1994-09-01), None
patent: WO 94/28024 (1994-12-01), None
patent: WO 95/11924 (1995-05-01), None
patent: WO 97/04796 (1997-02-01), None
patent: WO 98/32466 (1998-07-01), None
patent: WO-01/02017 (2001-01-01), None
patent: WO 01/02017 (2001-01-01), None
patent: WO 01/87329 (2001-11-01), None
patent: WO-2004/019972 (2004-03-01), None
patent: WO 2004/019972 (2004-03-01), None
patent: WO-2004/047858 (2004-06-01), None
patent: WO 2004/047858 (2004-06-01), None
patent: WO-2004/091495 (2004-10-01), None
patent: WO 2004/091495 (2004-10-01), None
US 5,733,746, 03/1998, Treco et al. (withdrawn)
Christodoulou et al., Eur. J. Intern. Med. Aug. 2000, vol. 11 (4), pp. 222-227.
Yamaguchi et al. ,The Journal of Biological Chemistry, vol. 266, No. 30, pp. 20434-20439, 1991.
March, J., Advanced Organic Chemistry, McGraw-Hill, pp. 375-376 (1977).
Grassetti, D. R. et al., Archives of Biochemistry and Biophysics. vol. 119, pp. 41-49 (1967).
Morpurgo M. et al., Bioconjugate Chem. vol. 7, pp. 363-368 (1996).
Hermanson G. T., Bioconjugate Techniques, Academic Press, San Diego pp. 147-149 (1996).
Annable L. et al., Bull. Wld. Health Org. vol. 47, pp. 99-112 (1972).
Lehmann P. et al., Poster presented at the AACC/CSCC Annual Meeting, Chicago, Illinois, Jul. 29-Aug. 2, 2001 (Abstract 95).
Abstract corresponding to DE 3924705 (B13).
Schreiber, Stefan, et al., New England Journal of Medicine, vol. 334, No. 10, pp. 619-623 (1996) XP008045816.
Gasche, Christoph, et al., Digestion, vol. 60, No. 3, pp. 262-267 (1999) XP008045815.
Gasche, C., et al., Digestive Diseases and Sciences, Plenum Publishing Co. US, vol. 39, No. 9, pp. 1930-1934 (1994) XP000616992.
Dohil, Ranjan, et al., Journal of Pediatrics, vol. 132, No. 1, pp. 155-159 (1998) XP008045656.
Wilson, Alisa, et al., American Journal of Medicine, vol. 116, No. Suppl. 7A, pp. 44-49 (2004) XP008045800.
Schreiber et al., “Rrecombinant erythropoietin for the treatment of anemia in inflammatory bowel disease,” New England Journal of Medicine, vol. 334, No. 10, 1996, pp. 619-623.
Gasche, et al., “Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin,” Digestion, vol. 60, No. 3, May 1999, pp. 262-267.
Gasche, et al., “Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency,” Digestive diseases and sciences, Plenum Publishing co. US, vol. 39, No. 9, Sep. 1, 1994, pp. 1930-1934.
Dohil, et al., “Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease,” Journal of Pediatrics, vol. 132, No. 1, Jan. 1998, pp. 155-159.
Wilson, et al., “Prevalence and outcomes of anemia in inflammatory bowel disease: A systematic review of the literature,” American Journal of Medicine, vol. 116, No. Suppl. 7A, Apr. 5, 2004, pp. 44-49.
Gasche, Christoph, Inflammatory Bowel Diseases, vol. 6, No. 2, pp. 142-150 (2000) XP001167179.
Klima Horst
Lehmann Paul
Roeddiger Ralf
Walter-Matsui Ruth
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Robinson Hope A
Tramaloni Dennis P.
LandOfFree
Method of treating disturbances of iron distribution in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating disturbances of iron distribution in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating disturbances of iron distribution in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024157